To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

Preclinical study results provide a comprehensive transcriptomic characterization of regenerative wound repair in the oral ...

A historic wall at the Brisbane Showgrounds adorned with murals from street artists has been demolished as part of the ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...